JP Morgan Chase
LFST icon

JP Morgan Chase’s Lifestance Health LFST Stock Holding History

JP Morgan Chase’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$986K Sell
158,016
-98,722
-38% -$687K ﹤0.01% 4623
2025
Q4 		$1.81M Buy
256,738
+16,085
+7% +$97.1K ﹤0.01% 4148
2025
Q3 		$1.32M Sell
240,653
-310,004
-56% -$1.52M ﹤0.01% 4380
2025
Q2 		$2.85M Buy
550,657
+51,154
+10% +$306K ﹤0.01% 3640
2025
Q1 		$3.33M Sell
499,503
-75,651
-13% -$575K ﹤0.01% 3496
2024
Q4 		$4.24M Buy
575,154
+480,518
+508% +$3.45M ﹤0.01% 3496
2024
Q3 		$662K Buy
94,636
+10,894
+13% +$65.5K ﹤0.01% 4733
2024
Q2 		$411K Sell
83,742
-7,597
-8% -$45.8K ﹤0.01% 4793
2024
Q1 		$564K Sell
91,339
-29,136
-24% -$196K ﹤0.01% 4729
2023
Q4 		$943K Sell
120,475
-86,410
-42% -$557K ﹤0.01% 4375
2023
Q3 		$1.42M Sell
206,885
-110,197
-35% -$893K ﹤0.01% 3818
2023
Q2 		$2.89M Buy
317,082
+207,269
+189% +$1.72M ﹤0.01% 3269
2023
Q1 		$816K Buy
109,813
+22,367
+26% +$124K ﹤0.01% 4183
2022
Q4 		$433K Buy
87,446
+1,394
+2% +$8.62K ﹤0.01% 4611
2022
Q3 		$569K Sell
86,052
-389,491
-82% -$2.72M ﹤0.01% 4369
2022
Q2 		$2.64M Buy
475,543
+191,691
+68% +$1.47M ﹤0.01% 3318
2022
Q1 		$2.87M Buy
283,852
+8,624
+3% +$75.7K ﹤0.01% 3474
2021
Q4 		$2.62M Buy
275,228
+7,083
+3% +$75.1K ﹤0.01% 3638
2021
Q3 		$3.89M Buy
268,145
+266,333
+14,698% +$5.13M ﹤0.01% 3253
2021
Q2 		$51K Buy
+1,812
New +$47.9K ﹤0.01% 5731

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SPIG
Silversmith Partners I GP Boston, Massachusetts $39.2M AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

JP Morgan Chase's LFST Position: Q1 2026 in Review

JP Morgan Chase reduced its Lifestance Health (LFST) stake by 38% in Q1 2026, selling an estimated $687K and leaving 158,016 shares worth $986K. The position accounts for ﹤0.01% of the portfolio, ranked #4623.

JP Morgan Chase first reported a position in LFST in Q2 2021 and has held it in 20 quarters since. The position peaked at $4.24M in Q4 2024. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • JP Morgan Chase held 158,016 shares of Lifestance Health worth $986K as of Q1 2026.
  • JP Morgan Chase sold 98,722 Lifestance Health shares in Q1 2026, an estimated $687K.
  • Lifestance Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4623 holding.
  • JP Morgan Chase first reported a position in Lifestance Health in Q2 2021 and has held it in 20 quarters since.
  • JP Morgan Chase's Lifestance Health position peaked at $4.24M in Q4 2024.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.